{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:15:26Z","timestamp":1767766526629,"version":"3.48.0"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["J. Abdom. Wall Surg."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The management of giant diaphragmatic paralysis remains a significant surgical challenge, frequently associated with high rates of recurrence and the risk of developing abdominal compartment syndrome. While the use of Botulinum Toxin Type A (BTX- A) as an adjuvant therapy has been established in complex ventral hernia repair, its application in diaphragmatic paralysis is novel and sparsely documented. This study aims to present our institutional experience with BTX-A as a prehabilitation strategy in patients with complex diaphragmatic paralysis and to evaluate short- and long-term outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>Three patients with complex diaphragmatic paralysis underwent preoperative administration as part of a prehabilitation protocol prior to surgical repair. Loss of domain (LD) was calculated using the Sabbagh formula. According to Sabbagh, LD is defined as the ratio of herniated volume to total peritoneal volume (LD = HV\/TPV), with a loss &amp;gt;20% being considered significant. All patients received a standardized BTX-A administration protocol consisting of ultrasound-guided injection of 500 units of botulinum toxin type A, administered at six sites following the technique described by Smoot, with three injection points on each side targeting the internal oblique muscle 4 weeks before surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Preoperative administration of Botulinum Toxin Type A (BTX-A) was safe in all three patients, with no postoperative complications or development of abdominal compartment syndrome, which was monitored through continuous intra-abdominal pressure measurements during the hospital stay (short-term outcomes). Six months postoperatively, all patients demonstrated significant improvement in respiratory function, assessed by standard pulmonary function tests, and reported improved quality of life, including relief from dyspnoea and enhanced daily functioning. At twelve months, two patients remained asymptomatic, with no clinical or radiological evidence of recurrence (long-term outcomes). Overall, preoperative BTX-A was associated with both short-term safety and sustained long-term functional benefits in this series.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Preoperative BTX-A appears to be safe and well-tolerated in complex diaphragmatic paralysis. The results suggest that BTX-A may reduce complications, improve functional outcomes, enhance respiratory function, and increase quality of life, with effects maintained for at least 1\u00a0year in most patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/jaws.2025.14476","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:10:09Z","timestamp":1767766209000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative Botulinum Toxin for Complex Diaphragmatic Paralysis: A Case Series"],"prefix":"10.3389","volume":"4","author":[{"given":"L.","family":"S\u00e1nchez Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Valera S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"Naranjo Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Morales-Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S2146","DOI":"10.1016\/j.athoracsur.2010.03.021","article-title":"Diaphragm Plication for Eventration or Paralysis: A Review of the Literature","volume":"89","author":"Groth","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3978\/j.issn.2072-1439.2012.s001","article-title":"Video Assisted Thoracoscopic Plication of the Left Hemidiaphragm in Symptomatic Eventration in Adulthood","volume":"4","author":"Visouli","year":"2012","journal-title":"J Thorac Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e767","DOI":"10.1097\/PEC.0000000000001765","article-title":"Diaphragmatic Pathology in Children: Not Always an Easy Diagnosis","volume":"37","author":"Moreno-Galarraga","year":"2021","journal-title":"Pediatr Emerg Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.athoracsur.2005.08.054","article-title":"Abdominal Compartment Syndrome: A Rare Complication of Plication of the Diaphragm","volume":"82","author":"Phadnis","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.surg.2021.03.027","article-title":"Fascial Closure in Giant Ventral Hernias After Preoperative Botulinum Toxin A and Progressive Pneumoperitoneum: A Systematic Review and Meta-Analysis","volume":"170","author":"Van Rooijen","year":"2021","journal-title":"Surgery"},{"key":"B6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/wjs.12112","article-title":"Effects of Botulinum Toxin in Two Indicators of Loss of Domain and Hernia Size Among Patients with Large Ventral Hernias","volume":"48","author":"Espinosa-de-Los-Monteros","year":"2024","journal-title":"World J Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10029-020-02226-2","article-title":"Implementing Preoperative Botulinum Toxin A and Progressive Pneumoperitoneum Through the Use of an Algorithm in Giant Ventral Hernia Repair","volume":"25","author":"Yurtkap","year":"2021","journal-title":"Hernia"},{"key":"B8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jss.2020.10.028","article-title":"The Effects of Preoperative Botulinum Toxin A Injection on Abdominal Wall Reconstruction","volume":"260","author":"Deerenberg","year":"2021","journal-title":"J Surg Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10029-023-02848-2","article-title":"Volumetry After Botulinum Toxin A: The Impact on Abdominal Wall Compliance and Endotracheal Pressure","volume":"28","author":"Amaral","year":"2024","journal-title":"Hernia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10029-023-02816-w","article-title":"Systematic Review and Meta-Analysis of the Pre-Operative Application of Botulinum Toxin for Ventral Hernia Repair","volume":"27","author":"Dias","year":"2023","journal-title":"Hernia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10029-019-01939-3","article-title":"Selective Muscle Botulinum Toxin A Component Paralysis in Complex Ventral Hernia Repair","volume":"24","author":"Elstner","year":"2020","journal-title":"Hernia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10029-019-01957-1","article-title":"Short-Term Safety of Preoperative Administration of Botulinum Toxin A for the Treatment of Large Ventral Hernia with Loss of Domain","volume":"24","author":"Nielsen","year":"2020","journal-title":"Hernia"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10029-011-0849-2","article-title":"Progressive Preoperative Pneumoperitoneum Preparation for Large Incisional Hernia Repair","author":"Sabbagh","year":"2012","journal-title":"Hernia"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/j.1526-4637.2011.01147.x","article-title":"Botox A Injection for Pain After Laparoscopic Ventral Hernia: A Case Report","volume":"12","author":"Smoot","year":"2011","journal-title":"Pain Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.3390\/jcm12165301","article-title":"Minimally-Invasive Diaphragmatic Plication in Patients with Unilateral Diaphragmatic Paralysis","volume":"12","author":"Beshay","year":"2023","journal-title":"J Clin Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.rehah.2015.02.002","article-title":"Empleo De Toxina Botul\u00ednica En Pared Abdominal Como Tratamiento Previo a La Reparaci\u00f3n Quir\u00fargica De Una Hernia De Morgagni Gigante","volume":"3","author":"Barber Millet","year":"2015","journal-title":"Rev Hispanoam Hernia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e53836","DOI":"10.7759\/cureus.53836","article-title":"Adjuvant Botulinum Toxin Type A on the Management of Giant Hiatal Hernia: A Case Report","volume":"16","author":"Henriques","year":"2024","journal-title":"Cureus"},{"key":"B18","doi-asserted-by":"publisher","first-page":"13448","DOI":"10.3389\/jaws.2024.13448","article-title":"Area of Focus in 3D Volumetry and Botulinum Toxin A Injection for Giant Diaphragmatic Hernia with Loss of Domain: A Case Report with Video Illustration","volume":"3","author":"Nachtergaele","year":"2024","journal-title":"J Abdom Wall Surg"}],"container-title":["Journal of Abdominal Wall Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/jaws.2025.14476\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:10:11Z","timestamp":1767766211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/jaws.2025.14476\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":18,"alternative-id":["10.3389\/jaws.2025.14476"],"URL":"https:\/\/doi.org\/10.3389\/jaws.2025.14476","relation":{},"ISSN":["2813-2092"],"issn-type":[{"value":"2813-2092","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"article-number":"14476"}}